Overview

A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Status:
Completed

Trial end date:
2016-09-01

Target enrollment:

Participant gender:

Summary

The objectives of the study is to evaluate the efficacy, safety, and dose of DS-8500a compared with placebo in patients with type 2 diabetes mellitus.

Phase:

N/A

Details

Lead Sponsor:

Daiichi Sankyo Co., Ltd.

Treatments:

Firuglipel
Sitagliptin Phosphate